noscript

News and Announcements

Riccardo Canevari of Radiopharm Theranostics (ASX:RAD)

  • Published December 06, 2022 6:49AM UTC
  • Publisher Maan Perez
  • Categories CEO Interviews

Radiopharm Theranostics (ASX:RAD) is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The company has a pipeline of four distinct and highly differentiated platform technologies spanning peptides, small molecules, and monoclonal antibodies for use in cancer, from some of the world’s leading universities and institutes.

Watch this interview with CEO Riccardo Canevari as he discusses how they approach oncology with their unique processes.

CEO Interviews

View All
The Index Approach in Early-Stage Venture Capital: Reconsidered
Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Read more
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Read more
View All

Join over 45,000+ sophisticated investors

Join Now